Legal Opinion from Beijing Guofeng Law Firm on the First Extraordinary Shareholders' Meeting of Shandong Sanyuan Biotechnology Co., Ltd. in 2026
Beijing Guofeng Law Firm (hereinafter referred to as "this Firm") has been entrusted by Shandong Sanyuan Biotechnology Co., Ltd. (your company) to appoint lawyers to attend and witness your company's first extraordinary shareholders' meeting in 2026 (hereinafter referred to as "this meeting"). The lawyers of this Firm have issued this legal opinion based on the provisions of the Company Law of the People's Republic of China (hereinafter referred to as "Company Law"), the Securities Law of the People's Republic of China (hereinafter referred to as "Securities Law"), the Rules for Shareholders' Meetings of Listed Companies (hereinafter referred to as "Shareholders' Meeting Rules"), the Administrative Measures for Law Firms Engaging in Securities Legal Business (hereinafter referred to as "Securities Legal Business Management Measures"), the Trial Implementation Rules for Law Firms' Securities Legal Business (hereinafter referred to as "Securities Legal Business Practice Rules"), and other relevant laws, administrative regulations, rules, normative documents, and the Articles of Association of Shandong Sanyuan Biotechnology Co., Ltd. (hereinafter referred to as "Articles of Association"), regarding the convening and holding procedures of this meeting, the qualifications of the convener, the qualifications of attendees, the voting procedures, and the voting results.